KORU Medical Systems Inc (KRMD)
3.08
-0.12
(-3.75%)
USD |
NASDAQ |
Nov 14, 16:00
2.89
-0.19
(-6.17%)
After-Hours: 20:00
KORU Medical Systems Research and Development Expense (Quarterly): 1.134M for June 30, 2024
Research and Development Expense (Quarterly) Chart
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 1.134M |
| March 31, 2024 | 1.476M |
| December 31, 2023 | 1.288M |
| September 30, 2023 | 1.293M |
| June 30, 2023 | 1.597M |
| March 31, 2023 | 1.565M |
| December 31, 2022 | 1.642M |
| September 30, 2022 | 0.8621M |
| June 30, 2022 | 1.304M |
| March 31, 2022 | 1.148M |
| December 31, 2021 | 0.9499M |
| September 30, 2021 | 0.80M |
| June 30, 2021 | 0.3869M |
| March 31, 2021 | 0.3368M |
| December 31, 2020 | 0.3521M |
| September 30, 2020 | 0.3904M |
| June 30, 2020 | 0.2982M |
| March 31, 2020 | 0.256M |
| December 31, 2019 | 0.29M |
| September 30, 2019 | 0.1703M |
| June 30, 2019 | 0.1782M |
| March 31, 2019 | 0.102M |
| December 31, 2018 | 0.0804M |
| September 30, 2018 | 0.1269M |
| June 30, 2018 | 0.024M |
| Date | Value |
|---|---|
| March 31, 2018 | 0.0098M |
| September 30, 2017 | 0.0149M |
| June 30, 2017 | 0.0248M |
| February 28, 2017 | 0.054M |
| November 30, 2016 | 0.0591M |
| August 31, 2016 | 0.0677M |
| May 31, 2016 | 0.0567M |
| February 29, 2016 | 0.0633M |
| November 30, 2015 | 0.0516M |
| August 31, 2015 | 0.0387M |
| May 31, 2015 | 0.0537M |
| February 28, 2015 | 0.0614M |
| November 30, 2014 | 0.1169M |
| August 31, 2014 | 0.1584M |
| May 31, 2014 | 0.1314M |
| February 28, 2014 | 0.0864M |
| November 30, 2013 | 0.0509M |
| August 31, 2013 | 0.0431M |
| May 31, 2013 | 0.0378M |
| February 28, 2013 | 0.0361M |
| November 30, 2012 | 0.0361M |
| August 31, 2012 | 0.037M |
| May 31, 2012 | 0.0384M |
| February 29, 2012 | 0.041M |
| November 30, 2011 | 0.0266M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
0.256M
Minimum
Mar 2020
1.642M
Maximum
Dec 2022
0.9141M
Average
0.9499M
Median
Dec 2021
Research and Development Expense (Quarterly) Benchmarks
| Perspective Therapeutics Inc | 9.275M |
| Retractable Technologies Inc | 0.1991M |
| InfuSystems Holdings Inc | -- |
| Xtant Medical Holdings Inc | 0.636M |
| Catheter Precision Inc | 0.081M |